https://endpts.com/with-cash-in-the-bank-and-an-eye-on-europe-neurocrine-buys-out-a-london-based-outfit/
0
0
8/30/22 at 11:26am
Organization
Endpoints News
Author
Amber Tong
As rising sales for its lead product give Neurocrine some extra cash to work with, the biotech is jumping on a buyout. Just don’t look for anything huge. Neurocrine is acquiring London-based Diurnal Group for £48.3 million, or $56.57 million, in cash. On top …
Create an account
or login to join the discussion